BioNexus Gene Lab (BGLC) Stock Chart & Stock Price History $3.97 -1.12 (-22.00%) Closing price 04:00 PM EasternExtended Trading$3.98 +0.01 (+0.25%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock BioNexus Gene Lab Stock Price Performance The BioNexus Gene Lab (BGLC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 21.51%, with a year-to-date return of 41.94%. In the past month, the stock has increased 43.84%, reflecting recent market activity. As of the latest close, BioNexus Gene Lab traded at $5.09 with a market cap of $9.16 million and volume of 333,987 shares. Receive BGLC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioNexus Gene Lab and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-31.79%1 Month Performance+43.84%3 Month Performance+71.12%Year-To-Date Performance+41.94%1 Year Performance-21.51% BGLC Stock Chart for Monday, July, 14, 2025 BGLC Chart by TradingView BioNexus Gene Lab Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/14/2025$5.09$3.97-22.00%$4.91$3.85263,697 shs$7.15 million07/11/2025$6.04$5.09-15.73%$5.89$4.76333,987 shs$9.16 million07/10/2025$5.82$6.04+3.78%$6.39$5.68182,660 shs$10.85 million07/09/2025$6.39$5.82-8.92%$6.18$5.68185,751 shs$10.48 million07/08/2025$5.93$6.39+7.76%$6.42$5.51312,391 shs$11.50 million07/07/2025$6.31$5.93-6.01%$6.43$5.33347,863 shs$10.67 million07/04/2025$6.31$6.31$8.24$6.12932,080 shs$11.36 million07/03/2025$6.82$6.31-7.49%$8.24$6.12932,080 shs$11.36 million07/02/2025$11.14$6.82-38.78%$7.24$5.562.08 million shs$12.26 million07/01/2025$3.07$11.14+262.87%$15.60$8.8350.73 million shs$20.05 million Get the Latest News and Ratings for BGLC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioNexus Gene Lab and its competitors with MarketBeat's FREE daily newsletter. 06/30/2025$2.77$3.07+10.83%$3.33$2.72129,006 shs$5.53 million06/27/2025$2.71$2.77+2.21%$2.92$2.618,043 shs$4.99 million06/26/2025$2.62$2.71+3.44%$2.76$2.6514,933 shs$4.88 million06/25/2025$2.67$2.62-1.87%$2.70$2.608,220 shs$4.72 million06/24/2025$2.74$2.67-2.55%$2.88$2.6610,648 shs$4.81 million06/23/2025$2.87$2.74-4.53%$2.92$2.7132,411 shs$4.92 million06/20/2025$2.93$2.87-2.05%$3.06$2.7819,421 shs$5.17 million06/19/2025$2.93$2.93$3.05$2.819,763 shs$5.27 million06/18/2025$2.88$2.93+1.74%$3.05$2.819,763 shs$5.27 million06/17/2025$2.96$2.88-2.70%$3.10$2.8319,253 shs$5.18 million06/16/2025$2.76$2.96+7.25%$3.13$2.7749,109 shs$5.32 million06/13/2025$2.91$2.76-5.15%$2.95$2.7526,694 shs$4.96 million Related Companies PIII Stock Price Chart BDSX Stock Price Chart BNR Stock Price Chart BMGL Stock Price Chart CCM Stock Price Chart MRAI Stock Price Chart ENZ Stock Price Chart BRTX Stock Price Chart MGRX Stock Price Chart SSY Stock Price Chart Receive BGLC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioNexus Gene Lab and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BGLC) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn extra $1,000 per month?A little-known Title 15 provision could let you collect instant payouts — $100 to $1,000 — directly from your ...TradeSmith | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNexus Gene Lab Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNexus Gene Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
